Skip to main content
Premium Trial:

Request an Annual Quote

LifeMap Integrates Genomenon's Mastermind Genomics Search Engine

NEW YORK (GenomeWeb) – LifeMap Sciences will integrate Genomenon's Mastermind Genomic Search Engine into its GeneCards knowledge base, the companies announced today. The partnership will help researchers using GeneCards more easily identify relevant literature associated with genes, diseases, and variants, according to the firms. 

Ann Arbor, Michigan-based Genomenon is demonstrating the integration this week at the annual American College of Medical Genomics conference in Seattle.

Genomenon's Mastermind Genomic Search Engine allows clinicians to index nearly 5 million genomic variants from data found in scientific publications. The company has said that the tool helps doctors provide faster and better treatment decisions for patients with rare diseases and cancer.

GeneCards informs LifeMap's TGex clinical genomics platform, which features interpretation and analysis for structural variations based on phenotypes.

"This partnership puts the insight from millions of genomic research publications into the hands of TGex users to accelerate patient diagnosis and ensure that nothing has been missed in making patient treatment decisions," Genomenon CEO Mike Klein said in a statement. "Together with LifeMap Sciences, we’re also expanding the insight for researchers by linking genomic search results directly into the GeneCards platform, making it easier to find any publication covering the disease, gene, and variants of interest."

Alameda, California-based LifeMap is a subsidiary of BioTime spinout AgeX Therapeutics.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.